The keyword phrase here is recognition before use
All documented evaluations are confined to non-clinical experimental models, with no application beyond investigational and analytical research settings
This study demonstrates the pro-angiogenic effects of BPC 157 that is associated with the increased expression, internalization of VEGFR2, and the activation of VEGFR2-Akt-eNOS signaling pathway
Targeting Pericytes for Angiogenic Therapies
This directness translates to more predictable dosing and faster onset of effects
Unlike growth factors peptides, which need carrier(s) addition, and are rapidly degraded in human gastric juice, BPC 157, as an antiulcer peptide, is native and resistant to human gastric juice exciding one day period (Sikiric et al., 1993